文献速递胸部CT

动态灌注面积探测器CT评估伴进行性纤维化间质性肺病的I期非小细胞肺癌

Dynamic perfusion area-detector CT in non-small cell lung cancer with progressive fibrosing interstitial lung disease.
PubMed 文献 · Eur Radiol · 2025-05-22

研究纳入63例伴进行性纤维化间质性肺病的I期非小细胞肺癌患者,行动态对比增强灌注面积探测器CT并采用双输入最大斜率法生成总灌注、肺动脉灌注和体动脉灌注图,对切除肺内正常肺、肺气肿、磨玻璃影或无牵拉性支气管扩张的网状影、有牵拉性支气管扩张的网状影和蜂窝影进行多中心感兴趣区测量,方差分析及Tukey HSD检验显示各灌注参数在五组间有显著差异,联合灌注指标判别准确率显著高于各单一指标。

要点

  • 肺动脉灌注在异常肺组织显著低于正常肺(p<0.0001)。
  • 体动脉灌注在正常或肺气肿肺显著低于其他病变(p<0.0001)。
  • 联合灌注指标判别准确率显著高于各单一指标(p<0.0001)。

核心结论

  • 动态对比增强灌注面积探测器CT有助于检测伴进行性纤维化间质性肺病的I期非小细胞肺癌患者的病理结构改变。

研究设计与样本

  • 连续纳入63例伴进行性纤维化间质性肺病的I期非小细胞肺癌患者,行动态对比增强灌注面积探测器CT,采用双输入最大斜率法分析总灌注、肺动脉灌注和体动脉灌注图,并行手术治疗和病理检查。

关键影像表现/征象

  • 异常肺的肺动脉灌注显著低于正常肺(p<0.0001)。
  • 正常或肺气肿肺的体动脉灌注显著低于其他病变(p<0.0001)。
  • 磨玻璃影或无牵拉性支气管扩张的网状影的体动脉灌注显著低于有牵拉性支气管扩张的网状影和蜂窝影(p<0.0001)。

诊断标准与关键数值

  • 肺动脉灌注用于区分正常肺与异常肺,异常肺显著降低(p<0.0001)。
  • 体动脉灌注用于区分正常或肺气肿肺与其他病变,前者显著降低(p<0.0001)。
  • 体动脉灌注用于区分磨玻璃影或无牵拉性支气管扩张的网状影与有牵拉性支气管扩张的网状影和蜂窝影,前者显著降低(p<0.0001)。
  • 联合灌注指标的判别准确率显著高于各单一指标(p<0.0001)。

临床应用与阅片要点

  • 动态对比增强灌注面积探测器CT生成的灌注图可用于评估伴进行性纤维化间质性肺病的I期非小细胞肺癌患者肺实质改变。
  • 联合应用总灌注、肺动脉灌注和体动脉灌注指标可能提高对肺实质改变的判别准确率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the capability of dynamic contrast-enhanced (CE-) perfusion area-detector CT (ADCT) for detecting pathological structural changes in stage I non-small cell lung cancer (NSCLC) patients.

MATERIALS AND METHODS: Sixty-three consecutive stage I NSCLC patients with progressive fibrosing interstitial lung disease (PF-ILD) underwent dynamic CE-perfusion ADCT analyzed by dual-input maximum slope (DMS) methods for total, pulmonary arterial and systemic arterial perfusion (TPDMS, PAPDMS and SAPDMS) maps, surgical treatment and pathological examination. Multicentric ROIs were then placed over sites assessed as normal lung, pulmonary emphysema, GGO or reticular pattern without traction bronchiectasis, reticular pattern with traction bronchiectasis and honeycombing in the resected lung. Next, an analysis of variance (ANOVA) followed by Tukey's honest significant difference (HSD) multiple comparison test was performed for a comparison of each of the perfusion parameters for five groups. Finally, discrimination accuracy for evaluation of lung parenchymal change was compared for all indexes and combined methods.

RESULTS: PAPDMSs of abnormal lungs were significantly lower than that of normal lungs (p < 0.0001). SAPDMSs of normal or emphysematous lungs were significantly lower than those of others (p < 0.0001). SAPDMS of GGO or reticular pattern without traction bronchiectasis was significantly lower than that for reticular pattern with traction bronchiectasis and honeycombing (p < 0.0001). Discrimination accuracy of combined perfusion index was significantly higher than that of each index (p < 0.0001).

CONCLUSION: Dynamic CE-perfusion ADCT is useful for detecting pathological structural changes in stage I NSCLC patients with PF-ILD.

KEY POINTS: Question Can dynamic first-pass contrast-enhanced perfusion matrices evaluate parenchymal lung changes and disease severity of parenchymal diseases in stage I non-small cell lung cancer (NSCLC) patients? Findings Perfusion indexes differentiated significantly among normal lung, emphysema, GGO or reticular pattern without traction bronchiectasis, reticular pattern with traction bronchiectasis and honeycombing and significantly improved discrimination accuracy by combined methods. Clinical relevance Dynamic first-pass contrast-enhanced perfusion area-detector CT has the potential to assess underlying pathologies and pulmonary functional changes in stage I non-small cell carcinoma patients with progressive fibrosing interstitial lung disease.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ohno Y, Fujisawa Y, Yoshikawa T, et al. Dynamic perfusion area-detector CT in non-small cell lung cancer with progressive fibrosing interstitial lung disease. Eur Radiol. 2025. PMID: 40402289. doi:10.1007/s00330-025-11653-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。